Argomento: Salute
Topic Archive (11033 items) • Pagina 393
117_SRES_624
A resolution supporting the mission and goals of National Fentanyl Awareness Day in 2022, including increasing individual and public awareness of the impact of fake or counterfeit fentanyl pills on families and young people.
Aggiornato: 09/05/2022
117_S_4161
Clean Water Standards for PFAS 2.0 Act of 2022
Aggiornato: 09/05/2022
117_S_4163
CONSCIENCE Act
Aggiornato: 09/05/2022
117_HRES_1093
Expressing support for the designation of May 2022 as "Mental Health Awareness Month".
Aggiornato: 06/05/2022
117_HR_7669
Drug Shortages Shelf Life Extension Act
Aggiornato: 06/05/2022
117_HR_7671
Airborne Act
Aggiornato: 06/05/2022
117_HR_7672
Advancing Student Services In Schools Today Act
Aggiornato: 06/05/2022
117_HR_7679
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the authority to grant certain exemptions, and for other purposes.
Aggiornato: 06/05/2022
117_HR_7681
Preventing Overdoses and Saving Lives Act 2.0
Aggiornato: 06/05/2022
117_HR_7684
No Tax Breaks for Radical Corporate Activism Act
Aggiornato: 06/05/2022
117_S_4151
Stop Pills That Kill Act
Aggiornato: 05/05/2022
117_S_4152
A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
Aggiornato: 05/05/2022
117_S_4156
VA Workforce Improvement, Support, and Expansion (WISE) Act of 2022
Aggiornato: 05/05/2022
117_S_4157
LEAD Act of 2022
Aggiornato: 05/05/2022
117_S_4132
Women’s Health Protection Act of 2022
Aggiornato: 04/05/2022
117_S_4133
Expedited Disability Insurance Payments for Terminally Ill Individuals Act of 2022
Aggiornato: 04/05/2022
117_HR_7640
To amend the Orphan Drug Act to reauthorize a program of grants and contracts for the development of drugs for rare diseases and conditions (commonly referred to as "orphan drugs").
Aggiornato: 03/05/2022
117_HR_7644
Pride in Mental Health Act
Aggiornato: 03/05/2022
117_HR_7646
Emerging Signals Modernization Act of 2022
Aggiornato: 03/05/2022
117_HR_7649
To direct the Secretary of Health and Human Services to open a public docket for the submission of public comments regarding factors that should be taken into consideration when reviewing a proposed modification to an approved risk evaluation and mitigation strategy, and for other purposes.
Aggiornato: 03/05/2022